Company registration number 03787370 (England and Wales)
RAINBOW COSMETICS (HOLDINGS) LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
RAINBOW COSMETICS (HOLDINGS) LIMITED
COMPANY INFORMATION
Directors
J W Sharman
S J Sharman
Secretary
S J Ramsbottom
Company number
03787370
Registered office
61 Stanley Road
Whitefield
Manchester
M45 8GZ
Auditors
Sumer Auditco Limited
Fourth Floor
Unit 5B, The Parklands
Bolton
BL6 4SD
Bankers
HSBC Bank Plc
4 Hardman Square
Spinningfields
Manchester
M3 3EB
RAINBOW COSMETICS (HOLDINGS) LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 6
Statement of comprehensive income
7
Balance sheet
8
Statement of changes in equity
9
Notes to the financial statements
10 - 18
RAINBOW COSMETICS (HOLDINGS) LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 1 -

The directors present the strategic report for the year ended 31 December 2025.

Review of the business

During the year the company continued to act as a holding company. The company is not a trading company and as such no results are analysed.

On behalf of the board

S J Sharman
Director
16 September 2026
RAINBOW COSMETICS (HOLDINGS) LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -

The directors present their annual report and financial statements for the year ended 31 December 2025.

Principal activities

The principal activity of the company continued to be that of a holding company.

Results and dividends

The results for the year are set out on page 7.

No ordinary dividends were paid. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

J W Sharman
S J Sharman
Financial instruments
Liquidity risk

The company seeks to manage financial risk by ensuring liquidity is available to meet foreseeable needs. Short term flexibility is achieved through banking facilities and multilateral group support.

Credit risk

The company has both group and other debtors and therefore the company is exposed to risks of non-recovery of these debts from group companies and other debtors.

Future developments

The Directors remain committed to the continued development and growth of the Group’s brands. Management intends to further strengthen brand awareness and continue to expand the market presence both locally and internationally through innovative products and designs.

Auditor

The auditor, Sumer Auditco Limited, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

RAINBOW COSMETICS (HOLDINGS) LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

On behalf of the board
S J Sharman
Director
16 September 2026
RAINBOW COSMETICS (HOLDINGS) LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF RAINBOW COSMETICS (HOLDINGS) LIMITED
- 4 -
Opinion

We have audited the financial statements of Rainbow Cosmetics (Holdings) Limited (the 'company') for the year ended 31 December 2025 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

RAINBOW COSMETICS (HOLDINGS) LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF RAINBOW COSMETICS (HOLDINGS) LIMITED
- 5 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

We identified areas of laws and regulations that could reasonably be expected to have a material effect on the financial statements from our general commercial and sector experience, and through discussions with the directors (as required by auditing standards) and discussed with the directors the policies and procedures regarding compliance with laws and regulations. We communicated identified laws and regulations throughout our team and remained alert to any indications of non-compliance throughout the audit. The potential effect of these laws and regulations on the financial statements varies considerably.

Firstly, the company is subject to laws and regulations that directly affect the financial statements including financial reporting legislation and taxation legislation. We assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statement items.

Secondly, the company is subject to many other laws and regulations where the consequences of non-compliance could have a material effect on amounts or disclosures in the financial statements, for instance through the imposition of fines or litigation or the loss of the company's license to operate. We identified the following areas as those most likely to have such an effect: laws related to health and safety and employment laws.

Auditing standards limit the required audit procedures to identify non-compliance with these laws and regulations to enquiry of the directors and inspection of regulatory and legal correspondence, if any. Through these procedures we did not become aware of any actual or suspected non-compliance.

RAINBOW COSMETICS (HOLDINGS) LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF RAINBOW COSMETICS (HOLDINGS) LIMITED
- 6 -

Owing to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some

material misstatements in the financial statements, even though we have properly planned and performed our

audit in accordance with auditing standards. For example, the further removed non-compliance with laws and

regulations (irregularities) is from the events and transactions reflected in the financial statements, the less likely

the inherently limited procedures required by auditing standards would identify it. In addition, as with any audit,

there remained a higher risk of non-detection of irregularities, as these may involve collusion, forgery, intentional

omissions, misrepresentations, or the override of internal controls. We are not responsible for preventing noncompliance and cannot be expected to detect non-compliance with all laws and regulations.

We design procedures in line with our responsibilities, outlined below to detect material misstatement due to fraud:

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Alex Hesketh (Senior Statutory Auditor)
For and on behalf of Sumer Auditco Limited
17 September 2026
Fourth Floor
Unit 5B, The Parklands
Bolton
BL6 4SD
RAINBOW COSMETICS (HOLDINGS) LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
2025
2024
Notes
£
£
Turnover
-
-
Administrative expenses
(136,380)
(111,781)
Other operating income
150,000
150,000
Profit before taxation
13,620
38,219
Tax on profit
3
(2,922)
(9,489)
Profit for the financial year
10,698
28,730

The profit and loss account has been prepared on the basis that all operations are continuing operations.

RAINBOW COSMETICS (HOLDINGS) LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 8 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
5
367,474
269,346
Investments
6
1,506
1,506
368,980
270,852
Current assets
Debtors
8
5,387,583
5,480,421
Creditors: amounts falling due within one year
9
(5,710,794)
(5,717,238)
Net current liabilities
(323,211)
(236,817)
Total assets less current liabilities
45,769
34,035
Provisions for liabilities
Deferred tax liability
10
5,338
4,302
(5,338)
(4,302)
Net assets
40,431
29,733
Capital and reserves
Called up share capital
11
550
550
Capital redemption reserve
450
450
Profit and loss reserves
39,431
28,733
Total equity
40,431
29,733

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 16 September 2026 and are signed on its behalf by:
S J Sharman
Director
Company registration number 03787370 (England and Wales)
RAINBOW COSMETICS (HOLDINGS) LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 9 -
Share capital
Capital redemption reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 January 2024
550
450
5,705,659
5,706,659
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
28,730
28,730
Dividends
4
-
-
(5,705,656)
(5,705,656)
Balance at 31 December 2024
550
450
28,733
29,733
Year ended 31 December 2025:
Profit and total comprehensive income
-
-
10,698
10,698
Balance at 31 December 2025
550
450
39,431
40,431
RAINBOW COSMETICS (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 10 -
1
Accounting policies
Company information

Rainbow Cosmetics (Holdings) Limited is a private company limited by shares incorporated in England and Wales. The registered office is 61 Stanley Road, Whitefield, Manchester, M45 8GZ.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared on the historical cost convention, to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of H&J Sharman Holdings Limited. These consolidated financial statements are available from its registered office, Edward House, 61 Stanley Road, Whitefield, United Kingdom, M45 8GZ.

 

The company has taken advantage of the exemption under section 400 of the Companies Act not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about it's group.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future.

 

At the year end the company has net current liabilities of £323,211 (2024: £236,817) due to group loans. Net assets remain positive at £40,431 (2024: £29,733) due to the assets of the group being held in Rainbow Cosmetics (Holdings) Limited.

 

Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

RAINBOW COSMETICS (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 11 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
15% Straight Line
Computer equipment
25% Straight line
Motor vehicles
25% Straight Line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

RAINBOW COSMETICS (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 12 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Trade debtors, loans and other receivables that have fixed or determinable payments that are not quoted in an active market are classified as 'loans and receivables'. Loans and receivables are measured at amortised cost using the effective interest method, less any impairment.

 

Interest is recognised by applying the effective interest rate, except for short-term receivables when the recognition of interest would be immaterial. The effective interest method is a method of calculating the amortised cost of a debt instrument and of allocating the interest income over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash receipts through the expected life of the debt instrument to the net carrying amount on initial recognition.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

RAINBOW COSMETICS (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 13 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

RAINBOW COSMETICS (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 14 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
3
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
1,886
8,330
Deferred tax
Origination and reversal of timing differences
1,036
1,159
Total tax charge
2,922
9,489
RAINBOW COSMETICS (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
3
Taxation
(Continued)
- 15 -

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
Profit before taxation
13,620
38,219
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
3,405
9,555
Capital allowances
(1,036)
(988)
Movement in deferred taxation
1,036
1,159
Marginal relief
(483)
(237)
Tax expense for the year
2,922
9,489
4
Dividends
2025
2024
£
£
Interim paid
-
0
5,705,656
5
Tangible fixed assets
Fixtures, fittings & equipment
Computer equipment
Motor vehicles
Total
£
£
£
£
Cost
At 1 January 2025
521,020
585,398
413,480
1,519,898
Additions
4,475
16,990
215,543
237,008
Disposals
-
0
-
0
(22,945)
(22,945)
At 31 December 2025
525,495
602,388
606,078
1,733,961
Depreciation and impairment
At 1 January 2025
495,165
464,038
291,349
1,250,552
Depreciation charged in the year
10,870
43,292
84,718
138,880
Eliminated in respect of disposals
-
0
-
0
(22,945)
(22,945)
At 31 December 2025
506,035
507,330
353,122
1,366,487
Carrying amount
At 31 December 2025
19,460
95,058
252,956
367,474
At 31 December 2024
25,855
121,360
122,131
269,346
RAINBOW COSMETICS (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 16 -
6
Fixed asset investments
2025
2024
Notes
£
£
Investments in subsidiaries
7
1,506
1,506
7
Subsidiaries

Details of the company's subsidiaries at 31 December 2025 are as follows:

Name of undertaking
Address
Class of
% Held
shares held
Direct
Active Cosmetics Ltd
1
Ordinary
100.00
Face UK Ltd
1
Ordinary
100.00
Perfume Plus Ltd
1
Ordinary
100.00
Rainbow Cosmetics (Manchester) Limited
1
Ordinary
100.00
Brit Beauty Limited
3
Ordinary
100.00
SES Global Ltd
1
Ordinary
100.00
Seven Seas Merchants Ltd
1
Ordinary
100.00
Stanley Freight Services Ltd
1
Ordinary
100.00
Stanley Road Freight Services Ltd
1
Ordinary
100.00
Whitefield Logistics Ltd
1
Ordinary
100.00
Whitefield Transport Ltd
1
Ordinary
100.00
Worldwide Transport Limited
1
Ordinary
100.00
Rainbow Cosmetics Limited
2
Ordinary
100.00
M45 Logistics Limited
1
Ordinary
100.00

Registered office addresses (all UK unless otherwise indicated):

1
61 Stanley Road, Whitefield, Manchester, M45 8GZ
2
38 Main Street, Swords, Dublin, K67 E0A2
3
Fourth Floor Unit 5b, The Parklands, Lostock, Bolton, United Kingdom, BL6 4SD
8
Debtors
2025
2024
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
5,387,583
5,480,421
9
Creditors: amounts falling due within one year
2025
2024
£
£
Amounts owed to group undertakings
5,705,658
5,705,658
Corporation tax
1,886
8,330
Accruals and deferred income
3,250
3,250
5,710,794
5,717,238
RAINBOW COSMETICS (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 17 -
10
Deferred taxation

Deferred tax assets and liabilities are made up as follows:

 

Liabilities
Liabilities
2025
2024
Balances:
£
£
ACAs
5,338
4,302
2025
Movements in the year:
£
Liability at 1 January 2025
4,302
Charge to profit or loss
1,036
Liability at 31 December 2025
5,338

 

11
Share capital
2025
2024
£
£
Ordinary share capital
Issued and fully paid
550 Ordinary Shares of £1 each
550
550
12
Financial commitments, guarantees and contingent liabilities

The bank holds a multilateral guarantee dated 24 August 2010 between all group companies. The maximum potential liability at 31 December 2025 was £1,859,209 (2024: £1,452,952).

13
Related party transactions

The company has taken advantage of the exemption available in accordance with FRS 102 section 1.12(e) 'Related party disclosures' not to disclose transactions entered into between two or more members of a group, as the company is a wholly owned subsidiary undertaking of the group to which it is party to the transactions.

RAINBOW COSMETICS (HOLDINGS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 18 -
14
Controlling party

The ultimate parent company is H&J Sharman Holdings Limited, a company registered in England & Wales.

 

The largest and smallest group in which the results of the company are consolidated is headed by H&J Sharman Holdings Limited, incorporated in England and Wales. The consolidated accounts of this company are available to the public and may be obtained from Companies House, Crown Way, Cardiff, CF14 3UZ, or from the company’s registered office at Edward House, 61 Stanley Road, Whitefield, Manchester, M45 8GZ

 

 

H&J Shaman Holdings Limited, is ultimately controlled by H Sharman and J Sharman by virtue of their shareholding.

2025-12-312025-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.200J W SharmanS J SharmanS J Ramsbottom037873702025-01-012025-12-3103787370bus:Director12025-01-012025-12-3103787370bus:Director22025-01-012025-12-3103787370bus:CompanySecretary12025-01-012025-12-3103787370bus:RegisteredOffice2025-01-012025-12-3103787370bus:Agent12025-01-012025-12-31037873702025-12-31037873702024-01-012024-12-3103787370core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3103787370core:RetainedEarningsAccumulatedLosses2025-01-012025-12-31037873702024-12-3103787370core:FurnitureFittings2025-12-3103787370core:ComputerEquipment2025-12-3103787370core:MotorVehicles2025-12-3103787370core:FurnitureFittings2024-12-3103787370core:ComputerEquipment2024-12-3103787370core:MotorVehicles2024-12-3103787370core:WithinOneYear2025-12-3103787370core:WithinOneYear2024-12-3103787370core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3103787370core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3103787370core:ShareCapital2025-12-3103787370core:ShareCapital2024-12-3103787370core:CapitalRedemptionReserve2025-12-3103787370core:CapitalRedemptionReserve2024-12-3103787370core:RetainedEarningsAccumulatedLosses2025-12-3103787370core:RetainedEarningsAccumulatedLosses2024-12-3103787370core:ShareCapital2023-12-3103787370core:CapitalRedemptionReserve2023-12-3103787370core:RetainedEarningsAccumulatedLosses2023-12-3103787370core:ShareCapitalOrdinaryShareClass12025-12-3103787370core:ShareCapitalOrdinaryShareClass12024-12-3103787370core:FurnitureFittings2025-01-012025-12-3103787370core:ComputerEquipment2025-01-012025-12-3103787370core:MotorVehicles2025-01-012025-12-3103787370core:UKTax2025-01-012025-12-3103787370core:UKTax2024-01-012024-12-310378737012025-01-012025-12-310378737012024-01-012024-12-310378737022025-01-012025-12-310378737022024-01-012024-12-3103787370core:FurnitureFittings2024-12-3103787370core:ComputerEquipment2024-12-3103787370core:MotorVehicles2024-12-31037873702024-12-3103787370core:Non-currentFinancialInstruments2025-12-3103787370core:Non-currentFinancialInstruments2024-12-3103787370core:Subsidiary12025-01-012025-12-3103787370core:Subsidiary22025-01-012025-12-3103787370core:Subsidiary32025-01-012025-12-3103787370core:Subsidiary42025-01-012025-12-3103787370core:Subsidiary52025-01-012025-12-3103787370core:Subsidiary62025-01-012025-12-3103787370core:Subsidiary72025-01-012025-12-3103787370core:Subsidiary82025-01-012025-12-3103787370core:Subsidiary92025-01-012025-12-3103787370core:Subsidiary102025-01-012025-12-3103787370core:Subsidiary112025-01-012025-12-3103787370core:Subsidiary122025-01-012025-12-3103787370core:Subsidiary132025-01-012025-12-3103787370core:Subsidiary142025-01-012025-12-3103787370core:Subsidiary112025-01-012025-12-3103787370core:Subsidiary222025-01-012025-12-3103787370core:Subsidiary332025-01-012025-12-3103787370core:Subsidiary442025-01-012025-12-3103787370core:Subsidiary552025-01-012025-12-3103787370core:Subsidiary662025-01-012025-12-3103787370core:Subsidiary772025-01-012025-12-3103787370core:Subsidiary882025-01-012025-12-3103787370core:Subsidiary992025-01-012025-12-3103787370core:Subsidiary10102025-01-012025-12-3103787370core:Subsidiary11112025-01-012025-12-3103787370core:Subsidiary12122025-01-012025-12-3103787370core:Subsidiary13132025-01-012025-12-3103787370core:Subsidiary14142025-01-012025-12-3103787370core:CurrentFinancialInstruments2025-12-3103787370core:CurrentFinancialInstruments2024-12-3103787370bus:PrivateLimitedCompanyLtd2025-01-012025-12-3103787370bus:FRS1022025-01-012025-12-3103787370bus:Audited2025-01-012025-12-3103787370bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP